Role of adenosine A2b receptors in pulmonary microvascular endothelial inflammation induced by lipopolysaccharide / 中华危重病急救医学

ABSTRACT

Objective@#To explore the role of the low-affinity A2b adenosine receptors (Adora2b) in pulmonary microvascular endothelial inflammation induced by lipopolysaccharide and its mechanism.@*Methods@#Rat pulmonary microvascular endothelial cells (PMVECs) were isolated and cultured in vitro. After serum deprivation for 24 hours, cells were pretreated with Adora2b specific agonist BAY60-6583 (0.1, 1, 10 μmol/L) or Adora2b specific antagonist PSB1115 (1 μmol/L) for 1 hour, respectively, and then challenged with LPS (100 μg/L). Cells without treatment were served as the control group, and those treated with LPS, BAY60-6583 or PSB1115 alone were served as single challenge groups. After incubation with specific drugs for 24 hours, the apoptosis of PMVECs was analyzed by flow cytometry using Annexin V/propidium iodide (PI) technique. The levels of early inflammatory factors in cultured medium were measured using enzyme linked immunosorbent assay (ELISA). The mRNA expressions of chemotactic factors and adhesion molecules were determined by real-time quantitative-polymerase chain reaction (RT-qPCR). Polymorph nuclear neutrophils (PMNs) from venous blood of healthy rats were isolated, and PMN migration through PMVECs monolayer under stimulation of drugs was observed in transwell inserts. The monolayer permeability of PMVECs after adhesion of PMNs was determined by fluorescein isothiocyanate (FITC)-albumin assay. Oxidative stress was detected by DCFH-DA assay.@*Results@#Compared with the control group, more cells entered into the apoptosis stage after LPS challenge. Meanwhile, the levels of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in cultured medium were significantly increased, as well as the mRNA expressions of chemotactic factors [C-X-C motif chemokine ligand 1 (CXCL-1), CXCL-3 and monocyte chemoattractant protein-1 (MCP-1)] and adhesion molecules [E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)]. More PMNs migrated through PMVECs following adhesion and the monolayer permeability of PMVECs was rapidly enhanced. The oxidative stress was upregulated. Compared with LPS group, BAY60-6583 pretreatment could dose-dependently decrease the rate of apoptosis, attenuate trans-endothelial migration of PMNs and decrease the endothelial cell barrier leakage. There were significant differences even after incubation of 0.1 μmol/L BAY60-6583 [apoptosis rate (21.12±2.12)% vs. (27.66±3.57)%, number of migrated PMNs/HP 260.60±18.24 vs. 290.20±16.48, permeability coefficient (Pd, ×10-6 cm/s) 28.28±2.04 vs. 32.55±2.13, all P < 0.05]. Meanwhile, BAY60-6583 pretreatment also downregulated the levels of early proinflammatory factors in a dose-dependent manner as well as the mRNA expressions of chemotactic factors and adhesion molecules. The statistic difference was significant while treated with 1 μmol/L BAY60-6583 [IL-1β (ng/L) 475.75±63.15 vs. 755.25±67.42, TNF-α (ng/L) 560.25±69.96 vs. 818.75±60.92, CXCL-1 mRNA (2-ΔΔCt) 3.57±0.28 vs. 5.27±0.69, CXCL-3 mRNA (2-ΔΔCt) 4.56±0.48 vs. 7.32±0.54, MCP-1 mRNA (2-ΔΔCt) 2.21±0.31 vs. 3.35±0.21, E-selectin mRNA (2-ΔΔCt) 4.64±0.09 vs. 7.28±0.73, ICAM-1 mRNA (2-ΔΔCt) 4.14±0.30 vs. 5.89±0.25, VCAM-1 mRNA (2-ΔΔCt) 2.23±0.19 vs. 2.92±0.33, all P < 0.05]. Furthermore, pretreatment of 10 μmol/L BAY60-6583 could decrease the oxidative stress [reactive oxygen species (RFU) 629.05±33.10 vs. 781.45±64.59, P < 0.05]. Contrast, PSB1115 pretreatment aggravated apoptosis of PMVECs after LPS incubation [(34.36±4.57)% vs. (27.66±3.57)%], upregulated expressions of proinflammatory and chemotactic factors as well as adhesion molecules [IL-1β (ng/L) 889.00±63.11 vs. 755.25±67.42, TNF-α (ng/L) 939.00±43.44 vs. 818.75±60.92, CXCL-1 mRNA (2-ΔΔCt) 6.66±0.65 vs. 5.27±0.69, CXCL-3 mRNA (2-ΔΔCt) 10.42±0.51 vs. 7.32±0.54, MCP-1 mRNA (2-ΔΔCt) 4.85±0.34 vs. 3.35±0.21, E-selectin mRNA (2-ΔΔCt) 8.42±0.47 vs. 7.28±0.73, ICAM-1 mRNA (2-ΔΔCt) 7.46±0.72 vs. 5.89±0.25, VCAM-1 mRNA (2-ΔΔCt) 4.35±0.26 vs. 2.92±0.33], aggravated trans-endothelial migration of PMNs (cells/HP 348.40±22.68 vs. 290.20±16.48), enhanced the leakage of PMVECs monolayer [Pd (×10-6 cm/s) 39.65±2.69 vs. 32.55±2.13] and increased oxidative stress in PMVECs [reactive oxygen species (RFU) 847.04±29.26 vs. 781.45±64.59], with statistically significant difference (all P < 0.05).@*Conclusion@#Activation of endothelial Adora2b attenuates LPS-induced pulmonary microvascular inflammation by decreasing the release of early inflammatory factors, downregulating expressions of chemotactic factors and adhesion molecules, attenuating trans-endothelial migration of PMNs and oxidative stress in PMVECs, which suggest endothelial Adora2b is apotential anti-inflammatory target in the treatment of LPS-induced acute lung injury.